ELOCTATE

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerBioverativ Therapeutics Inc.

CountryUS (United States)

ATC code—

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 1

ndc11
7110480201
1 KIT in 1 KIT (71104-802-01) * 3 mL in 1 VIAL (71104-484-08) * 3 mL in 1 SYRINGE (71104-035-01)

Annotations

No annotations yet.

Raw payload (JSON)

{
  "route": "INTRAVENOUS",
  "productid": "71104-802_e600c559-32d8-4818-b600-141cc0d74cea",
  "productndc": "71104-802",
  "dosage_form": "KIT",
  "dea_schedule": null,
  "product_type": "PLASMA DERIVATIVE",
  "substance_name": null,
  "proprietary_name": "ELOCTATE",
  "active_ingred_unit": null,
  "application_number": "BLA125487",
  "marketing_category": "BLA",
  "nonproprietary_name": "Antihemophilic Factor (Recombinant), Fc Fusion Protein",
  "start_marketing_date": "20170906",
  "active_numerator_strength": null
}

Access this data programmatically

Query ELOCTATE and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs